Literature DB >> 15891767

Mismatch repair participates in error-free processing of DNA interstrand crosslinks in human cells.

Qi Wu1, Laura A Christensen, Randy J Legerski, Karen M Vasquez.   

Abstract

DNA interstrand crosslinks (ICLs) present formidable blocks to DNA metabolic processes and must be repaired for cell survival. ICLs are induced in DNA by intercalating compounds such as the widely used therapeutic agent psoralen. In bacteria, both nucleotide excision repair (NER) and homologous recombination are required for the repair of ICLs. The processing of ICLs in mammalian cells is not clearly understood. However, it is known that processing can occur by NER, which for psoralen ICLs can be an error-generating process conducive to mutagenesis. We show here that another repair pathway, mismatch repair (MMR), is also involved in eliminating psoralen ICLs in human cells. MMR deficiency renders cells hypersensitive to psoralen ICLs without diminishing their mutagenic potential, suggesting that MMR does not contribute to error-generating repair, and that MMR may represent a relatively error-free mechanism for processing these lesions in human cells. Thus, enhancement of MMR relative to NER may reduce the mutagenesis caused by DNA ICLs in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891767      PMCID: PMC1369090          DOI: 10.1038/sj.embor.7400418

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  32 in total

1.  Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells.

Authors:  I U De Silva; P J McHugh; P H Clingen; J A Hartley
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links.

Authors:  Y M Akkari; R L Bateman; C A Reifsteck; S B Olson; M Grompe
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 3.  The benefits and risks of long-term PUVA photochemotherapy.

Authors:  K Momtaz; T B Fitzpatrick
Journal:  Dermatol Clin       Date:  1998-04       Impact factor: 3.478

4.  P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.

Authors:  X Lin; K Ramamurthi; M Mishima; A Kondo; R D Christen; S B Howell
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

5.  Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway.

Authors:  A F Faruqi; H J Datta; D Carroll; M M Seidman; P M Glazer
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Psoralen photo-cross-linking by triplex-forming oligonucleotides at multiple sites in the human rhodopsin gene.

Authors:  B D Perkins; T G Wensel; K M Vasquez; J H Wilson
Journal:  Biochemistry       Date:  1999-09-28       Impact factor: 3.162

7.  Specific mutations induced by triplex-forming oligonucleotides in mice.

Authors:  K M Vasquez; L Narayanan; P M Glazer
Journal:  Science       Date:  2000-10-20       Impact factor: 47.728

8.  Mitotic recombination and localized DNA double-strand breaks are induced after 8-methoxypsoralen and UVA irradiation in Saccharomyces cerevisiae.

Authors:  M Dardalhon; B de Massy; A Nicolas; D Averbeck
Journal:  Curr Genet       Date:  1998-07       Impact factor: 3.886

9.  Targeted gene knockout mediated by triple helix forming oligonucleotides.

Authors:  A Majumdar; A Khorlin; N Dyatkina; F L Lin; J Powell; J Liu; Z Fei; Y Khripine; K A Watanabe; J George; P M Glazer; M M Seidman
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells.

Authors:  K M Vasquez; G Wang; P A Havre; P M Glazer
Journal:  Nucleic Acids Res       Date:  1999-02-15       Impact factor: 16.971

View more
  62 in total

Review 1.  The differences between ICL repair during and outside of S phase.

Authors:  Hannah L Williams; Max E Gottesman; Jean Gautier
Journal:  Trends Biochem Sci       Date:  2013-07-03       Impact factor: 13.807

2.  The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.

Authors:  Barbara Orelli; T Brooke McClendon; Oleg V Tsodikov; Tom Ellenberger; Laura J Niedernhofer; Orlando D Schärer
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

3.  Targeted gene correction using psoralen, chlorambucil and camptothecin conjugates of triplex forming peptide nucleic acid (PNA).

Authors:  Henrik Birkedal; Peter E Nielsen
Journal:  Artif DNA PNA XNA       Date:  2011-01

Review 4.  Repair of DNA lesions associated with triplex-forming oligonucleotides.

Authors:  Joanna Y Chin; Peter M Glazer
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

5.  LNA modification of single-stranded DNA oligonucleotides allows subtle gene modification in mismatch-repair-proficient cells.

Authors:  Thomas W van Ravesteyn; Marleen Dekker; Alexander Fish; Titia K Sixma; Astrid Wolters; Rob J Dekker; Hein P J Te Riele
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-07       Impact factor: 11.205

6.  Human HMGB1 directly facilitates interactions between nucleotide excision repair proteins on triplex-directed psoralen interstrand crosslinks.

Authors:  Sabine S Lange; Madhava C Reddy; Karen M Vasquez
Journal:  DNA Repair (Amst)       Date:  2009-05-14

7.  2,6-Dithiopurine blocks toxicity and mutagenesis in human skin cells exposed to sulfur mustard analogues, 2-chloroethyl ethyl sulfide and 2-chloroethyl methyl sulfide.

Authors:  K Leslie Powell; Stephen Boulware; Howard Thames; Karen M Vasquez; Michael C MacLeod
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

8.  Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.

Authors:  Yanan Sun; Lijun Tan; Huijun Li; Xiaowei Qin; Jiangtao Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1.

Authors:  Sarah A Martin; Nuala McCabe; Michelle Mullarkey; Robert Cummins; Darren J Burgess; Yusaku Nakabeppu; Sugako Oka; Elaine Kay; Christopher J Lord; Alan Ashworth
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

10.  Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks.

Authors:  Junhua Zhao; Aklank Jain; Ravi R Iyer; Paul L Modrich; Karen M Vasquez
Journal:  Nucleic Acids Res       Date:  2009-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.